ArticlePDF AvailableLiterature Review

Alternative modes of mechanical ventilation: A review for the hospitalist

Authors:

Abstract and Figures

Newer ventilators can be set to modes other than the pressure-control and volume-control modes of older machines. In this paper, the authors review several of these alternative modes (adaptive pressure control, adaptive support ventilation, proportional assist ventilation, airway pressure-release ventilation, biphasic positive airway pressure, and high-frequency oscillatory ventilation), explaining how they work and contrasting their theoretical benefits and the actual evidence of benefit.
Content may be subject to copyright.
EDUARDO MIRELES-CABODEVILA, MD
Department of Pulmonary and Critical Care Medicine,
University of Arkansas for Medical Sciences,
Little Rock, AR
Alternative modes of mechanical
ventilation: A review for the hospitalist
ABSTRACT
Newer ventilators can be set to modes other than the
pressure-control and volume-control modes of older ma-
chines. In this paper, the authors review several of these
alternative modes (adaptive pressure control, adap-
tive support ventilation, proportional assist ventilation,
airway pressure-release ventilation, biphasic positive
airway pressure, and high-frequency oscillatory ventila-
tion), explaining how they work and contrasting their
theoretical benefits and the actual evidence of benefit.
KEY POINTS
The alternative modes of ventilation were developed
to prevent lung injury and asynchrony, promote better
oxygenation and faster weaning, and be easier to use.
However, evidence of their benefit is scant.
Until now, we have lacked a standard nomenclature for
mechanical ventilation, leading to confusion.
Regardless of the mode used, the goals are to avoid
lung injury, keep the patient comfortable, and wean the
patient from mechanical ventilation as soon as possible.
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
417
T
  and computer-
ized control of mechanical ventilators
have made it possible to deliver ventilatory
assistance in new modes. Driving these in-
novations is the desire to prevent ventilator-
induced lung injury, improve patient comfort,
and liberate the patient from mechanical ven-
tilation as soon as possible.
We call these innovations “alternative”
modes to differentiate them from the plain
volume-control and pressure-control modes.
Some clinicians rarely use these new modes,
but in some medical centers they have become
the most common ones used, or are being used
unknowingly (the operator misunderstands
the mode name). The information we provide
on these modes of ventilation is by no means
an endorsement of their use, but rather a tool
to help the clinician understand their physi-
ologic, theoretical, and clinical effects.
We focused on two goals:
Explain what the mode does•
Briey review the theoretical benets and •
the actual evidence supporting these alter-
native modes of ventilation.
STANDARD NOMENCLATURE NEEDED
Since its invention, mechanical ventilation
has been plagued by multiple names being used
to describe the same things. For example, vol-
ume-control ventilation is also called volume-
cycled ventilation, assist-control ventilation,
volume-limited ventilation, and controlled
mechanical ventilation. Similarly, multiple
abbreviations are used, each depending on the
brand of ventilator, and new acronyms have
been added in recent years as new modes have
been developed. The vast number of names
REVIEW
*Mr. Chatburn has disclosed that he has received fees from Cardinal Health for serving on
advisory committees or review panels and from Strategic Dynamics Inc for consulting.
doi:10.3949/ccjm.76a.08043
ENRIQUE DIAZ-GUZMAN, MD
Respiratory Institute,
Cleveland Clinic
GUSTAVO A. HERESI, MD
Respiratory Institute,
Cleveland Clinic
ROBERT L. CHATBURN, BS, RRT-NPS*
Respiratory Institute, Respiratory Therapy Section,
Cleveland Clinic
Abbreviations used in this article
APC—adaptive pressure control
APRV—airway pressure-release ventilation
ASV—adaptive support ventilation
CPAP—continuous positive airway pressure
Fio2—fraction of inspired oxygen
HFOV—high-frequency oscillatory ventilation
PAV—proportional assist ventilation
PEEP—positive end-expiratory pressure
PSV—pressure support ventilation
EDUCATIONAL OBJECTIVE: Readers will be able to explain what some of the new ventilator modes do
and their theoretical and actual benefits
CREDIT
CME
418
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
and modes can confuse even the most sea-
soned critical care physician.
Efforts to establish a common nomencla-
ture are under way.1
WHAT IS A MODE?
A mode of mechanical ventilation has three
essential components:
The control variable•
The breath sequence•
The targeting scheme.•
Similar modes may require more detailed
descriptions to distinguish them, but the basic
function can be explained by these three com-
ponents.
The control variable
In general, inspiration is an active process,
driven by the patient’s effort, the ventilator, or
both, while expiration is passive. For simplic-
ity, in this article a mechanical breath means
the inspiratory phase of the breath.
The machine can only control the volume
(and ow) or the pressure given. The breaths
can be further described on the basis of what
triggers the breath, what limits it (the maxi-
mum value of a control variable), and what
ends (cycles) it.
Therefore, a volume-controlled breath is
triggered by the patient or by the machine,
limited by ow, and cycled by volume (FIGURE
1). A pressure-controlled breath is triggered by
the patient or the machine, limited by pres-
sure, and cycled by time or ow (FIGURE 1).
The breath sequence
There are three possible breath sequences:
Continuous mandatory ventilation, in •
which all breaths are controlled by the
machine (but can be triggered by the pa-
tient)
Intermittent mandatory ventilation, in •
which the patient can take spontaneous
breaths between mandatory breaths
Continuous spontaneous ventilation, in •
which all breaths are spontaneous (TABLE 1).
The targeting scheme
The targeting or feedback scheme refers to
the ventilator settings and programming that
dictate its response to the patient’s lung com-
pliance, lung resistance, and respiratory effort.
The regulation can be as simple as controlling
the pressure in pressure-control mode, or it
can be based on a complicated algorithm.
The mode
name can be
misleading
Tidal volume
set by operator
Inspiratory pressure
set by operator
Airway
pressure
Patient
effort
Larger respiratory
effort
Small respiratory
effort
No respiratory
effort
Volume
Flow
FIGURE 1. Volume control (top) and pressure control (bottom) are modes of continuous mandatory
ventilation. Each mode is depicted as patient effort increases. Notice that the mode’s control variable
(volume or pressure) remains constant as patient effort increases. Contrast these findings with those
in FIGURE 2.
Volume control
Pressure control
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
419
MIRELES-CABODEVILA AND COLLEAGUES
In the sections that follow, we describe some
of the available alternative modes of mechani-
cal ventilation. We will explain only the tar-
geting schemes in the modes reviewed (TABLE 1,
TABLE 2), but more information on other target-
ing schemes can be found elsewhere.1,2 We will
focus on evidence generated in adult patients
receiving invasive mechanical ventilation.
ADAPTIVE PRESSURE CONTROL
One of the concerns with pressure-control ven-
tilation is that it cannot guarantee a minimum
minute ventilation (the volume of air that
goes in and out in 1 minute; the tidal volume
× breaths per minute) in the face of changing
lung mechanics or patient effort, or both. To
solve this problem, in 1991 the Siemens Servo
300 ventilator (Siemens, Maquet Critical Care
AB, Solna, Sweden) introduced Pressure Reg-
ulated Volume Control, a mode that delivers
pressure-controlled breaths with a target tidal
volume and that is otherwise known as adap-
tive pressure control (APC) (FIGURE 2).
Other names for adaptive pressure control
Pressure Regulated Volume Control (Ma-•
quet Servo-i, Rastatt, Germany)
A mode
of ventilation
is only as good
as the operator
who applies it
TABLE 1
Mechanical breath terminology
Mechanical breath description
Control variable—the mechanical breath goal, ie, a set pressure or a set volume
Trigger variable—that which starts inspiration, ie, the patient (generating changes in pressure or flow)
or a set rate (time between breaths)
Limit variable—the maximum value during inspiration
Cycle variable—that which ends inspiration
Breath sequence
Continuous mandatory ventilation—all breaths are controlled by the ventilator, so usually they have the
same characteristics regardless of the trigger (patient or set rate); no spontaneous breaths are allowed
Intermittent mandatory ventilation—a set number of mechanical breaths is delivered regardless of the
trigger (patient initiation or set rate); spontaneous breaths are allowed between or during mandatory
breaths
Continuous spontaneous ventilation—all breaths are spontaneous with or without assistance
Type of control or targeting scheme a
Set point—the ventilator delivers and maintains a set goal, and this goal is constant (eg, in pressure
control, the set point is pressure, which will remain constant throughout the breath); to a degree, all modes
have some set-point control scheme
Servo—the ventilator adjusts its output to a given patient variable (ie, in proportional assist ventilation,
the inspiratory flow follows and amplifies the patient’s own flow pattern)
Adaptive—the ventilator adjusts a set point to maintain a different operator-selected set point (ie, in
pressure-regulated volume control, the inspiratory pressure is adjusted breath to breath to achieve a target
tidal volume)
Optimal—the ventilator uses a mathematical model to calculate the set points to achieve a goal (ie, in
adaptive support ventilation, the pressure, respiratory rate, and tidal volume are adjusted to achieve a goal
minute ventilation)
a Mentioned in this review; for more information, refer to Chatburn1
420
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
AutoFlow (Dräger Medical AG, Lübeck, •
Germany)
Adaptive Pressure Ventilation (Hamilton •
Galileo, Hamilton Medical AG, Bonaduz,
Switzerland)
Volume Control+ (Puritan Bennett, Tyco •
Healthcare; Manseld, MA)
Volume Targeted Pressure Control, Pres-•
sure Controlled Volume Guaranteed (Eng-
ström, General Electric, Madison, WI).
What does adaptive pressure control do?
The APC mode delivers pressure-controlled
breaths with an adaptive targeting scheme
(TABLE 2).
In pressure-control ventilation, tidal vol-
umes depend on the lung’s physiologic mechan-
ics (compliance and resistance) and patient
effort (FIGURE 1). Therefore, the tidal volume
varies with changes in lung physiology (ie,
larger or smaller tidal volumes than targeted).
Mechanical
breaths can be
delivered only
via pressure
control or
volume control
TABLE 2
Classification of modes of ventilation
CONTROL VARIABLE BREATH SEQUENCE TARGETING SCHEME EXAMPLES OF COMMERCIALLY AVAILABLE MODES
Volume Continuous
mandatory
ventilation
Set point Volume control, VC-A/C, CMV, (S)CMV,
Assist/Control
Dual CMV + pressure limited
Adaptive Adaptive flow
Intermittent
mandatory
ventilation
Set point SIMV, VC-SIMV
Dual SIMV + pressure limited
Adaptive AutoMode (VC-VS), mandatory minute volume
Pressure Continuous
mandatory
ventilation
Set point Pressure control, PC-A/C, AC PCV,
high-pressure oscillatory ventilation a
Adaptive Pressure-regulated volume control, a VC+AC a,
AMV+AutoFlow a
Intermittent
mandatory
ventilation
Set point Airway pressure-release ventilation, a
SIMV PCV, BiLevel, a PCV+ a
Adaptive VC+SIMV, V V+SIMV APVSIMV,
SIMV+AutoFlow, Automode (PRVC-VS)
Optimal Adaptive support ventilation a
Continuous
spontaneous
ventilation
Set point Continuous positive airway pressure,
pressure support
Dual Volume assured pressure support,
volume augment
Servo Proportional assist ventilation, a automatic
tube compensation
Adaptive Volume support
Intelligent SmartCare
Three levels of classification of the modes of mechanical ventilation. As noted in the text, for a given combination of control vari-
able, breath sequence, and targeting scheme, several commercial mode names are described. Each commercial mode name can
have subtle differences from others in the same class; however, the main characteristics of the mode can be determined by this
classification.
a Discussed in this paper
CMV = continuous mandatory ventilation, CSV = continuous spontaneous ventilation, IMV = intermittent mandatory ventilation,
SIMV = synchronized intermittent mandatory ventilation
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
421
MIRELES-CABODEVILA AND COLLEAGUES
To overcome this effect, a machine in APC
mode adjusts the inspiratory pressure to deliver
the set minimal target tidal volume. If tidal vol-
ume increases, the machine decreases the in-
spiratory pressure, and if tidal volume decreases,
the machine increases the inspiratory pressure.
However, if the patient effort is large enough,
the tidal volume will increase in spite of decreas-
ing the inspiratory pressure (FIGURE 2). The adjust-
ments to the inspiratory pressure occur after the
tidal volume is off-target in a number of breaths.
Common sources of confusion
with adaptive pressure control
First, APC is not a volume-control mode. In
volume control, the tidal volume does not
change; in APC the tidal volume can increase
or decrease, and the ventilator will adjust the
ination pressure to achieve the target volume.
Thus, APC guarantees an average minimum
tidal volume but not a maximum tidal volume.
Second, a characteristic of pressure con-
trol (and hence, APC) is that the ow of gas
varies to maintain constant airway pressure
(ie, maintain the set inspiratory pressure).
This characteristic allows a patient who gen-
erates an inspiratory effort to receive ow as
demanded, which is likely more comfortable.
This is essentially different from volume con-
trol, in which ow is set by the operator and
hence is xed. Thus, if the patient effort is
strong enough (FIGURE 1), this leads to what is
called ow asynchrony, in which the patient
does not get the ow asked for in a breath.
Ventilator settings
in adaptive pressure control
Ventilator settings in APC are:
Tidal volume•
Time spent in inspiration (inspiratory time)•
Frequency•
Fraction of inspired oxygen (Fi• 2)
Positive end-expiratory pressure (PEEP).•
Some ventilators also require setting the
speed to reach the peak pressure (also known
as slope percent or inspiratory rise time).
Clinical applications
of adaptive pressure control
This mode is designed to maintain a consis-
tent tidal volume during pressure-control
ventilation and to promote inspiratory ow
synchrony. It is a means of automatically re-
ducing ventilatory support (ie, weaning) as
the patient’s inspiratory effort becomes stron-
ger, as in awakening from anesthesia.
The response of
the ventilator
to the patient is
regulated in a
number of ways
Target tidal volume
set by operator
Target tidal volume
set by operator
Inspiratory pressure is
adjusted to maintain
a target tidal volume
Larger respiratory
effort
Small respiratory
effort
No respiratory
effort
Airway
pressure
Patient
effort
Volume
Flow
Pressure
FIGURE 2. A machine in adaptive pressure control mode (top) adjusts the inspiratory pressure to main-
tain a set tidal volume. Adaptive support ventilation (bottom) automatically selects the appropriate
tidal volume and frequency for mandatory breaths and the appropriate tidal volume for spontaneous
breaths on the basis of the respiratory system mechanics and the target minute ventilation.
Adaptive support ventilation
Adaptive pressure control
422
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
APC adjusts
the inspira-
tory pressure
to deliver the
set target tidal
volume
APC may not be ideal for patients who
have an inappropriately increased respira-
tory drive (eg, in severe metabolic acidosis),
since the inspiratory pressure will decrease to
maintain the targeted average tidal volume,
inappropriately shifting the work of breathing
onto the patient.
Theoretical benefits
of adaptive pressure control
APC guarantees a minimum average tidal vol-
ume (unless the pressure alarm threshold is set
too low, so that the target tidal volume is not
delivered). Other theoretical benets are ow
synchrony, less ventilator manipulation by the
operator, and automatic weaning of ventilator
support.
Evidence of benefit
of adaptive pressure control
Physiologic benets. This mode has lower
peak inspiratory pressures than does volume-
control ventilation,3,4 which is often reported
as a positive nding. However, in volume-
control mode (the usual comparator), the
peak inspiratory pressure is a manifestation of
both resistance and compliance. Hence, peak
inspiratory pressure is expected to be higher
but does not reect actual lung-distending
pressures. It is the plateau pressure, a manifes-
tation of lung compliance, that is related to
lung injury.
Patient comfort. APC may increase the
work of breathing when using low tidal vol-
ume ventilation and when there is increased
respiratory effort (drive).5 Interestingly, APC
was less comfortable than pressure support
ventilation in a small trial.6
Outcomes have not been studied.7
Adaptive pressure control: Bottom line
APC is widely available and widely used,
sometimes unknowingly (eg, if the operator
thinks it is volume control). It is relatively
easy to use and to set; however, evidence of its
benet is scant.
ADAPTIVE SUPPORT VENTILATION
Adaptive support ventilation (ASV) evolved
as a form of mandatory minute ventilation
implemented with adaptive pressure control.
Mandatory minute ventilation is a mode that
allows the operator to preset a target minute
ventilation, and the ventilator then supplies
mandatory breaths, either volume- or pres-
sure-controlled, if the patient’s spontaneous
breaths generate a lower minute ventilation.
ASV automatically selects the appropri-
ate tidal volume and frequency for mandatory
breaths and the appropriate tidal volume for
spontaneous breaths on the basis of the respi-
ratory system mechanics and target minute
alveolar ventilation.
Described in 1994 by Laubscher et al,8,9
ASV became commercially available in 1998
in Europe and in 2007 in the United States
(Hamilton Galileo ventilator, Hamilton Med-
ical AG). This is the rst commercially avail-
able ventilator that uses an “optimal” target-
ing scheme (see below).
What does adaptive support ventilation do?
ASV delivers pressure-controlled breaths us-
ing an adaptive (optimal) scheme (TABLE 2).
“Optimal,” in this context, means minimizing
the mechanical work of breathing: the ma-
chine selects a tidal volume and frequency that
the patient’s brain would presumably select if
the patient were not connected to a ventila-
tor. This pattern is assumed to encourage the
patient to generate spontaneous breaths.
The ventilator calculates the normal re-
quired minute ventilation based on the pa-
tient’s ideal weight and estimated dead space
volume (ie, 2.2 mL/kg). This calculation
represents 100% of minute ventilation. The
clinician at the bedside sets a target percent
of minute ventilation that the ventilator will
support—higher than 100% if the patient has
increased requirements due, eg, to sepsis or in-
creased dead space, or less than 100% during
weaning.
The ventilator initially delivers test
breaths, in which it measures the expiratory
time constant for the respiratory system and
then uses this along with the estimated dead
space and normal minute ventilation to calcu-
late an optimal breathing frequency in terms
of mechanical work.
The optimal or target tidal volume is calcu-
lated as the normal minute ventilation divid-
ed by the optimal frequency. The target tidal
volume is achieved by the use of APC (see
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
423
MIRELES-CABODEVILA AND COLLEAGUES
above) (FIGURE 2). This means that the pressure
limit is automatically adjusted to achieve an
average delivered tidal volume equal to the
target. The ventilator continuously monitors
the respiratory system mechanics and adjusts
its settings accordingly.
The ventilator adjusts its breaths to avoid
air trapping by allowing enough time to ex-
hale, to avoid hypoventilation by delivering
tidal volume greater than the dead space, and
to avoid volutrauma by avoiding large tidal
volumes.
Ventilator settings
in adaptive support ventilation
Ventilator settings in ASV are:
Patient height (to calculate the ideal body •
weight)
Sex•
Percent of normal predicted minute ven-•
tilation goal
Fi• 2
PEEP.•
Clinical applications
of adaptive support ventilation
ASV is intended as a sole mode of ventila-
tion, from initial support to weaning.
Theoretical benefits
of adaptive support ventilation
In theory, ASV offers automatic selection of
ventilator settings, automatic adaptation to
changing patient lung mechanics, less need
for human manipulation of the machine, im-
proved synchrony, and automatic weaning.
Evidence of benefit
of adaptive support ventilation
Physiologic benets. Ventilator settings
are adjusted automatically. ASV selects dif-
ferent tidal volume-respiratory rate combina-
tions based on respiratory mechanics in passive
and paralyzed patients.10–12 In actively breath-
ing patients, there was no difference in the
ventilator settings chosen by ASV for differ-
ent clinical scenarios (and lung physiology).10
Compared with pressure-controlled intermit-
tent mandatory ventilation, with ASV, the
inspiratory load is less and patient-ventilator
interaction is better.13
Patient-ventilator synchrony and com-
fort have not been studied.
Outcomes. Two trials suggest that
ASV may decrease time on mechanical
ventilation.14,15 However, in another trial,16
compared with a standard protocol, ASV led
to fewer ventilator adjustments but achieved
similar postsurgical weaning outcomes. The
effect of this mode on the death rate has not
been examined.17,18
Adaptive support ventilation: Bottom line
ASV is the rst commercially available mode
that automatically selects all the ventilator
settings except PEEP and F2. These seem
appropriate for different clinical scenarios
in patients with poor respiratory effort or in
paralyzed patients. Evidence of the effect in
actively breathing patients and on outcomes
such as length of stay or death is still lack-
ing.
PROPORTIONAL ASSIST VENTILATION
Patients who have normal respiratory drive
but who have difculty sustaining adequate
spontaneous ventilation are often subjected
to pressure support ventilation (PSV), in
which the ventilator generates a constant
pressure throughout inspiration regardless of
the intensity of the patient’s effort.
In 1992, Younes and colleagues19,20 devel-
oped proportional assist ventilation (PAV) as
an alternative in which the ventilator gen-
erates pressure in proportion to the patient’s
effort. PAV became commercially available
in Europe in 1999 and was approved in the
United States in 2006, available on the Puri-
tan Bennett 840 ventilator (Puritan Bennett
Co, Boulder, CO). PAV has also been used for
noninvasive ventilation, but this is not avail-
able in the United States.
Other names for proportional
assist ventilation
Proportional Pressure Support (Dräger Medi-
cal; not yet available in the United States).
What does proportional
assist ventilation do?
This mode delivers pressure-controlled
breaths with a servo control scheme (TABLE 2).
To better understand PAV, we can compare
APC
is not a
volume-
controlled
mode
424
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
ASV selects
a tidal volume
and frequency
that the
patient’s
brain would
presumably
select
it with PSV. With PSV, the pressure applied by
the ventilator rises to a preset level that is held
constant (a set-point scheme) until a cycling
criterion (a percent of the maximum inspirato-
ry ow value) is reached. The inspiratory ow
and tidal volume are the result of the patient’s
inspiratory effort, the level of pressure applied,
and the respiratory system mechanics.
In contrast, during PAV, the pressure applied
is a function of patient effort: the greater the
inspiratory effort, the greater the increase in ap-
plied pressure (servo targeting scheme) (FIGURE
3). The operator sets the percentage of support
to be delivered by the ventilator. The ventila-
tor intermittently measures the compliance and
resistance of the patient’s respiratory system and
the instantaneous patient-generated ow and
volume, and on the basis of these it delivers a
proportional amount of inspiratory pressure.
In PAV, as in PSV, all breaths are spontane-
ous (TABLE 1). The patient controls the timing
and size of the breath. There are no preset pres-
sure, ow, or volume goals, but safety limits on
the volume and pressure delivered can be set.
Ventilator settings
in proportional assist ventilation
Ventilator settings in PAV are:
Airway type (endotracheal tube, trache-•
ostomy)
Airway size (inner diameter)•
Percentage of work supported (assist range •
5%–95%)
Tidal volume limit•
Pressure limit•
Expiratory sensitivity (normally, as inspi-•
ration ends, ow should stop; this param-
eter tells the ventilator at what ow to end
inspiration).
Caution when assessing the literature.
Earlier ventilator versions, ie, Dräger and Man-
itoba (University of Manitoba, Winnipeg, MB,
Canada), which are not available in the United
States, required the repeated calculation of the
respiratory system mechanics and the manual
setting of ow and volume assists (amplication
factors) independently. To overcome this limi-
tation, new software automatically adjusts the
ow and volume amplication to support the
loads imposed by the automatically measured
values of resistance and elastance (inverse of
compliance) of the respiratory system.21 This
software is included in the model (Puritan Ben-
nett) available in the United States.
Clinical applications
of proportional assist ventilation
The PAV mode is indicated for maximizing
ventilator patient synchrony for assisted spon-
taneous ventilation.
PAV is contraindicated in patients with
respiratory depression (bradypnea) or large air
leaks (eg, bronchopleural stulas). It should
be used with caution in patients with severe
hyperination, in which the patient may still
be exhaling but the ventilator doesn’t recog-
nize it. Another group in which PAV should
be used with caution is those with high ven-
tilatory drives, in which the ventilator over-
estimates respiratory system mechanics. This
situation can lead to overassistance due to the
“runaway phenomenon,” in which the venti-
Ventilator measuring
respiratory system
characteristics
Flow, pressure, and volume delivered
by the ventilator are adjusted
proportionally to patient effort
Patient
effort
Volume
Flow
Pressure
FIGURE 3. In proportional assist ventilation, the flow, pressure, and volume delivered are adjusted
proportionally to the patient’s effort.
Proportional assist ventilation
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
425
MIRELES-CABODEVILA AND COLLEAGUES
In PAV, the
greater the
inspiratory
effort, the
greater the
increase in
applied
pressure
lator continues to provide support even if the
patient has stopped inspiration.22
Theoretical benefits
of proportional assist ventilation
In theory, PAV should reduce the work of
breathing, improve synchrony, automatically
adapt to changing patient lung mechanics and
effort, decrease the need for ventilator inter-
vention and manipulation, decrease the need
for sedation, and improve sleep.
Evidence of benefit
of proportional assist ventilation
Physiologic benets. PAV reduces the work
of breathing better than PSV,21 even in the
face of changing respiratory mechanics or in-
creased respiratory demand (hypercapnia).23–25
The hemodynamic prole is similar to that in
PSV. Tidal volumes are variable; however, in
recent reports the tidal volumes were within
the lung-protective range (6–8 mL/kg, plateau
pressure < 30 cm H20).26,27
Comfort. PAV entails less patient effort
and discomfort that PSV does.23,25 PAV sig-
nicantly reduces asynchrony,27 which in turn
may favorably affect sleep in critically ill pa-
tients.28
Outcomes. The probability of spontaneous
breathing without assistance was signicantly
better in critically ill patients ventilated with
PAV than with PSV. No trial has reported the
effect of PAV on deaths.27,29
Proportional assist ventilation: Bottom line
Extensive basic research has been done with
PAV in different forms of respiratory failure,
such as obstructive lung disease, acute respira-
tory distress syndrome (ARDS), and chronic re-
spiratory failure. It fullls its main goal, which is
to improve patient-ventilator synchrony. Clini-
cal experience with PAV in the United States is
limited, as it was only recently approved.
AIRWAY PRESSURE-RELEASE
VENTILATION AND
BIPHASIC POSITIVE AIRWAY PRESSURE
Airway pressure-release ventilation (APRV)
was described in 1987 by Stock et al30 as a
mode for delivering ventilation in acute lung
injury while avoiding high airway pressures.
APRV combines high constant positive airway
pressure (improving oxygenation and promot-
ing alveolar recruitment) with intermittent
releases (causing exhalation).
In 1989, Baum et al31 described bipha-
sic positive airway pressure ventilation as a
mode in which spontaneous ventilation could
be achieved at any point in the mechanical
ventilation cycle—inspiration or exhalation
(FIGURE 4). The goal was to allow unrestricted
spontaneous breathing to reduce sedation and
promote weaning. These modes are conceptu-
ally the same, the main difference being that
the time spent in low pressure (Tlow; see be-
low) is less than 1.5 seconds for APRV. Other-
wise, they have identical characteristics, thus
allowing any ventilator with the capability
of delivering APRV to deliver biphasic posi-
tive airway pressure, and vice versa. Machines
with these modes became commercially avail-
able in the mid 1990s.
Other names for biphasic positive airway
pressure
Other names for biphasic positive airway pres-
sure are:
BiLevel (Puritan Bennett)•
BIPAP (Dräger Europe)•
Bi Vent (Siemens)•
BiPhasic (Avea, Cardinal Health, Inc, •
Dublin, OH)
PCV+ (Dräger Medical)•
DuoPAP (Hamilton).•
Caution—name confusion. In North
America, BiPAP (Respironics, Murrysville,
PA) and BiLevel are used to refer to noninva-
sive modes of ventilation.
APRV has no other name.
What do these modes do?
These modes deliver pressure-controlled,
time-triggered, and time-cycled breaths us-
ing a set-point targeting scheme (TABLE 2). This
means that the ventilator maintains a con-
stant pressure (set point) even in the face of
spontaneous breaths.
Caution—source of confusion. The term
continuous positive airway pressure (CPAP)
is often used to describe this mode. However,
CPAP is pressure that is applied continuously
at the same level; the patient generates all
the work to maintain ventilation (“pressure-
426
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
controlled continuous spontaneous ventila-
tion” in the current nomenclature). In APRV,
the airway pressure is intermittently released
and reapplied, generating a tidal volume that
supports ventilation. In other words, this is
a pressure-controlled breath with a very pro-
longed inspiratory time and a short expiratory
time in which spontaneous ventilation is pos-
sible at any point (“pressure-controlled inter-
mittent mandatory ventilation” in the current
nomenclature).
How these modes are set in the ventilator
may also be a source of confusion. To describe
the time spent in high and low airway pres-
sures, we use the terms Thigh and Tlow, respec-
tively. By convention, the difference between
APRV and biphasic mode is the duration of
Tlow (< 1.5 sec for APRV).
Similarly, Phigh and Plow are used to describe
the high and low airway pressure. To better un-
derstand this concept, you can create the same
mode in conventional pressure-control venti-
lation by thinking of the Thigh as the inspiratory
time, the Tlow as the expiratory time, the Phigh as
inspiratory pressure, and the Plow as PEEP.
Hence, APRV is an extreme form of in-
verse ratio ventilation, with an inspiration-to-
expiration ratio of 4:1. This means a patient
spends most of the time in Phigh and Thigh, and
exhalations are short (Tlow and Plow). In con-
trast, the biphasic mode uses conventional
inspiration-expiration ratios (FIGURE 4).
As with any form of pressure control, the
tidal volume is generated by airway pressure
rising above baseline (ie, the end-expiratory
value). Hence, to ensure an increase in minute
ventilation, the mandatory breath rate must
be increased (ie, decreasing Thigh, Tlow, or both)
or the tidal volume must be increased (ie, in-
creasing the difference between Phigh and Plow).
This means that in APRV the Tlow has to hap-
pen more often (by increasing the number of
breaths) or be more prolonged (allowing more
air to exhale). Because unrestricted spontane-
ous breaths are permitted at any point of the
cycle, the patient contributes to the total min-
ute ventilation (usually 10%–40%).
In APRV and biphasic mode, the opera-
tor’s set time and pressure in inspiration and
expiration will be delivered regardless of the
patient’s breathing efforts—the patient’s spon-
taneous breath does not trigger a mechanical
breath. Some ventilators have automatic ad-
justments to improve the trigger synchrony.
Spontaneous breaths occur
at any point without altering
the ventilator-delivered
breaths
Thigh:Tlow = 4:1Phigh and Thigh Plow and Tlow
Thigh:Tlow = 1:1–4
Phigh and Thigh Plow and Tlow
Volume
Pressure
FIGURE 4. Airway pressure-release ventilation (top) and biphasic positive airway pressure (bottom)
are forms of pressure-controlled intermittent mandatory ventilation in which spontaneous breaths
can occur at any point without altering the ventilator-delivered breaths. The difference is that the
time spent in high pressure is greater in airway pressure-release ventilation.
Biphasic positive airway pressure
Airway pressure-release ventilation
APRV allows
spontaneous
breaths at any
point in the
cycle
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
427
MIRELES-CABODEVILA AND COLLEAGUES
Ventilator settings
in APRV and biphasic mode
These modes require the setting of two pressure
levels (Phigh and Plow) and two time durations
(Thigh and Tlow). One can add pressure support
or automatic tube compensation to assist spon-
taneous breaths. The difference in Tlow gener-
ates differences in the Thigh:Tlow ratio: APRV
has a short Tlow (an inspiration-expiration ra-
tio of 4:1). Biphasic mode has a conventional
inspiration-expiration ratio of 1:1 to 1:4.
Clinical applications
APRV is used in acute lung injury and
ARDS. This mode should be used with cau-
tion or not at all in patients with obstructive
lung disease or inappropriately increased re-
spiratory drive.32–35
Biphasic mode is intended for both venti-
lation and weaning. In a patient who has poor
respiratory effort or who is paralyzed, bipha-
sic is identical to pressure-control/continuous
mandatory ventilation.
Theoretical benefits
of APRV and biphasic mode
Multiple benets have been ascribed to these
modes. In theory, APRV will maximize and
maintain alveolar recruitment, improve oxy-
genation, lower ination pressures, and decrease
overination. Both APRV and biphasic, by pre-
serving spontaneous breathing, will improve
ventilation-perfusion matching and gas diffusion,
improve the hemodynamic prole (less need for
vasopressors, higher cardiac output, reduced ven-
tricular workload, improved organ perfusion),
and improve synchrony (decrease the work of
breathing and the need for sedation).
Evidence of benefit of APRV
and biphasic mode
APRV and biphasic are different modes.
However studies evaluating their effects are
combined. This is in part the result of the no-
menclature confusion and different practice in
different countries.36
Physiologic benets. In studies, sponta-
neous breaths contributed to 10% to 40% of
minute ventilation,37,38 improved ventilation
of dependent areas of the lung, improved ven-
tilation-perfusion match and recruitment,39
and improved hemodynamic prole.40
Patient comfort. These modes are
thought to decrease the need for analgesia
and sedation,38 but a recent trial showed no
difference with pressure-controlled intermit-
tent mandatory ventilation.41 Patient venti-
lator synchrony and comfort have not been
studied.32,42
Outcomes. In small trials, these modes
made no difference in terms of deaths, but
they may decrease the length of mechanical
ventilation.38,41,43,44
APRV and biphasic mode: Bottom line
Maintaining spontaneous breathing while on
mechanical ventilation has hemodynamic and
ventilatory benets.
APRV and biphasic mode are not the same
thing. APRV’s main goal is to maximize mean
airway pressure and, hence, lung recruitment,
whereas the main goal of the biphasic mode is
synchrony.
There is a plethora of ventilator settings and
questions related to physiologic effects.33,34,36
Although these modes are widely used in
some centers, there is no evidence yet that
they are superior to conventional volume- or
pressure-control ventilation with low tidal vol-
ume for ARDS and acute lung injury. There is
no conclusive evidence that these modes im-
prove synchrony, time to weaning, or patient
comfort.
HIGH-FREQUENCY
OSCILLATORY VENTILATION
High-frequency oscillatory ventilation
(HFOV) was rst described and patented in
1952 by Emerson and was clinically developed
in the early 1970s by Lunkenheimer.45
The goal of HFOV is to minimize lung
injury; its characteristics (discussed below)
make it useful in patients with severe ARDS.
The US Food and Drug Administration ap-
proved it for infants in 1991 and for children
in 1995. The adult model has been available
since 1993, but it was not approved until 2001
(SensorMedics 3100B, Cardinal Health, Inc).
Other names for high-frequency
oscillatory ventilation
While HFOV has no alternative names, the
following acronyms describe similar modes:
Maintaining
spontaneous
breathing while
on mechanical
ventilation has
benefits
428
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
HFPPV (high-frequency positive pressure •
ventilation)
HFJV (high-frequency jet ventilation)•
HFFI (high-frequency ow interruption)•
HFPV (high-frequency percussive ventila-•
tion)
HFCWO (high-frequency chest wall oscil-•
lation).
All of these modes require different spe-
cialized ventilators.
What does high-frequency
oscillatory ventilation do?
Conceptually, HFOV is a form of pressure-
controlled intermittent mandatory venti-
lation with a set-point control scheme. In
contrast to conventional pressure-controlled
intermittent mandatory ventilation, in which
relatively small spontaneous breaths may be
superimposed on relatively large mandatory
breaths, HFOV superimposes very small man-
datory breaths (oscillations) on top of sponta-
neous breaths.
HFOV can be delivered only with a spe-
cial ventilator. The ventilator delivers a
constant ow (bias ow), while a valve cre-
ates resistance to maintain airway pressure,
on top of which a piston pump oscillates at
frequencies of 3 to 15 Hz (160–900 breaths/
minute). This creates a constant airway pres-
sure with small oscillations (FIGURE 5); often,
clinicians at the bedside look for the “chest
wiggle” to assess the appropriate amplitude
settings, although this has not been system-
atically studied.
Adult patients are usually paralyzed or
deeply sedated, since deep spontaneous
breathing will trigger alarms and affect venti-
lator performance.
To manage ventilation (CO2 clearance),
one or several of the following maneuvers can
be done: decrease the oscillation frequency,
increase the amplitude of the oscillations, in-
crease the inspiratory time, or increase bias
ow (while allowing an endotracheal tube cuff
leak). Oxygenation adjustments are controlled
by manipulating the mean airway pressure and
the F2.
Ventilator settings
in high-frequency oscillatory ventilation
Ventilator settings in HFOV are46:
Airway pressure amplitude (delta P or •
power)
Mean airway pressure•
Percent inspiration•
Inspiratory bias ow•
F• 2.
Clinical applications
of high-frequency oscillatory ventilation
This mode is usually reserved for ARDS pa-
tients for whom conventional ventilation is
failing. A recently published protocol46 sug-
gests considering HFOV when there is oxy-
genation failure (F2 ≥ 0.7 and PEEP ≥ 14 cm
H2O) or ventilation failure (pH < 7.25 with
tidal volume ≥ 6 mL/kg predicted body weight
and plateau airway pressure ≥ 30 cm H2O).
This mode is contraindicated when
there is known severe airow obstruction or
intracranial hypertension.
Frequency
Mean airway
pressure
Tidal volume
Airway pressure
amplitude (power)
FIGURE 5. High-frequency oscillatory ventilation delivers very small mandatory breaths (oscillations)
at frequencies of up to 900 breaths per minute.
The goal
of HFOV
is to minimize
lung injury,
especially
in ARDS
High-frequency oscillatory ventilation
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
429
MIRELES-CABODEVILA AND COLLEAGUES
Theoretical benefits
of high-frequency oscillatory ventilation
Conceptually, HFOV can provide the high-
est mean airway pressure paired with the low-
est tidal volume of any mode. These benets
might make HFOV the ideal lung-protective
ventilation strategy.
Evidence of benefit
of high-frequency oscillatory ventilation
Physiologic benets. Animal models have
shown less histologic damage and lung inam-
mation with HFOV than with high-tidal-
volume conventional ventilation47,48 and low-
tidal-volume conventional ventilation.49
Patient comfort has not been studied.
However, current technology does impose
undue work of breathing in spontaneously
breathing patients.50
Outcomes. Several retrospective case se-
ries have described better oxygenation with
HFOV as rescue therapy for severe ARDS
than with conventional mechanical ventila-
tion. Two randomized controlled trials have
studied HFOV vs high-tidal-volume conven-
tional mechanical ventilation for early severe
ARDS; HFOV was safe but made no differ-
ence in terms of deaths.42,51–54
High-frequency oscillatory ventilation:
Bottom line
In theory, HFOV provides all the benets of an
ideal lung-protective strategy, at least for para-
lyzed or deeply sedated patients. Animal stud-
ies support these concepts. In human adults,
HFOV has been shown to be safe and to pro-
vide better oxygenation but no improvement
in death rates compared with conventional
mechanical ventilation. Currently, HFOV is
better reserved for patients with severe ARDS
for whom conventional mechanical ventila-
tion is failing.
REFERENCES
1. Chatburn RL. Classification of ventilator modes: update and pro-
posal for implementation. Respir Care 2007; 52:301–323.
2. Chatburn RL. Computer control of mechanical ventilation. Respir
Care 2004; 49:507–517.
3. Alvarez A, Subirana M, Benito S. Decelerating flow ventilation ef-
fects in acute respiratory failure. J Crit Care 1998; 13:21–25.
4. Guldager H, Nielsen SL, Carl P, Soerensen MB. A comparison of
volume control and pressure regulated volume control ventilation
in acute respiratory failure. Crit Care 1997; 1:75–77.
5. Kallet RH, Campbell AR, Dicker RA, Katz JA, Mackersie RC. Work of
breathing during lung protective ventilation in patients with acute
lung injury and acute respiratory distress syndrome: a comparison
between volume and pressure regulated breathing modes. Respir
Care 2005; 50:1623–1631.
6. Betensley AD, Khalid I, Crawford J, Pensler RA, DiGiovine B. Patient
comfort during pressure support and volume controlled continuous
mandatory ventilation. Respir Care 2008; 53:897–902.
7. Branson RD, Chatburn RL. Controversies in the critical care setting.
Should adaptive pressure control modes be utilized for virtually
all patients receiving mechanical ventilation? Respir Care 2007;
52:478–485.
8. Laubscher TP, Frutiger A, Fanconi S, Jutzi H, Brunner JX. Automatic
selection of tidal volume, respiratory frequency and minute ventila-
tion in intubated ICU patients as start up procedure for closed-loop
controlled ventilation. Int J Clin Monit Comput 1994; 11:19–30.
9. Laubscher TP, Heinrichs W, Weiler N, Hartmann G, Brunner JX. An
adaptive lung ventilation controller. IEEE Trans Biomed Eng 1994;
41:51–59.
10. Arnal JM, Wysocki M, Nafati C, et al. Automatic selection of breath-
ing pattern using adaptive support ventilation. Intensive Care Med
2008; 34:75–81.
11. Campbell RS, Sinamban RP, Johannigman JA, et al. Clinical evalu-
ation of a new closed loop ventilation mode: adaptive supportive
ventilation (ASV). Crit Care 1999; 3(suppl 1):083.
12. Belliato M, Palo A, Pasero D, Iotti GA, Mojoli F, Braschi A. Evaluation
of adaptive support ventilation in paralysed patients and in a physi-
cal lung model. Int J Artif Organs 2004; 27:709–716.
13. Tassaux D, Dalmas E, Gratadour P, Jolliet P. Patient ventilator
interactions during partial ventilatory support: a preliminary study
comparing the effects of adaptive support ventilation with synchro-
nized intermittent mandatory ventilation plus inspiratory pressure
support. Crit Care Med 2002; 30:801–807.
14. Gruber PC, Gomersall CD, Leung P, et al. Randomized controlled trial
comparing adaptive-support ventilation with pressure-regulated
volume-controlled ventilation with automode in weaning patients
after cardiac surgery. Anesthesiology 2008; 109:81–87.
15. Sulzer CF, Chiolero R, Chassot PG, et al. Adaptive support ventila-
tion for fast tracheal extubation after cardiac surgery: a randomized
controlled study. Anesthesiology 2001; 95:1339–1345.
16. Petter AH, Chiolèro RL, Cassina T, Chassot PG, Müller XM, Revelly
JP. Automatic “respirator/weaning” with adaptive support ventila-
tion: the effect on duration of endotracheal intubation and patient
management. Anesth Analg 2003; 97:1743–1750.
17. Brunner JX, Iotti GA. Adaptive support ventilation (ASV). Minerva
Anestesiol 2002; 68:365–368.
18. Campbell RS, Branson RD, Johannigman JA. Adaptive support venti-
lation. Respir Care Clin North Am 2001; 7:425–440.
19. Younes M. Proportional assist ventilation, a new approach to venti-
latory support. Theory. Am Rev Respir Dis 1992; 145:114–120.
20. Younes M, Puddy A, Roberts D, et al. Proportional assist ventilation.
Results of an initial clinical trial. Am Rev Respir Dis 1992; 145:121–
129.
21. Kondili E, Prinianakis G, Alexopoulou C, Vakouti E, Klimathianaki M,
Georgopoulos D. Respiratory load compensation during mechanical
ventilatio—proportional assist ventilation with load-adjustable gain
factors versus pressure support. Intensive Care Med 2006; 32:692–
699.
22. Kondili E, Prinianakis G, Alexopoulou C, Vakouti E, Klimathianaki
M, Georgopoulos D. Effect of different levels of pressure support
and proportional assist ventilation on breathing pattern, work of
breathing and gas exchange in mechanically ventilated hypercap-
nic COPD patients with acute respiratory failure. Respiration 2003;
70:355–361.
23. Grasso S, Puntillo F, Mascia L, et al. Compensation for increase in re-
spiratory workload during mechanical ventilation. Pressure support
versus proportional assist ventilation. Am J Respir Crit Care Med
2000; 161:819–826.
24. Wrigge H, Golisch W, Zinserling J, Sydow M, Almeling G, Burchardi
430
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 76 • NUMBER 7 JULY 2009
MECHANICAL VENTILATION
H. Proportional assist versus pressure support ventilation: effects on
breathing pattern and respiratory work of patients with chronic ob-
structive pulmonary disease. Intensive Care Med 1999; 25:790–798.
25. Ranieri VM, Giuliani R, Mascia L, et al. Patient ventilator interaction
during acute hypercapnia: pressure support vs. proportional assist
ventilation. J Appl Physiol 1996; 81:426–436.
26. Kondili E, Xirouchaki N, Vaporidi K, Klimathianaki M, Georgopoulos
D. Short-term cardiorespiratory effects of proportional assist and
pressure support ventilation in patients with acute lung injury/acute
respiratory distress syndrome. Anesthesiology 2006; 105:703–708.
27. Xirouchaki N, Kondili E, Vaporidi K, et al. Proportional assist ven-
tilation with load-adjustable gain factors in critically ill patients:
comparison with pressure support. Intensive Care Med 2008;
34:2026–2034.
28. Bosma K, Ferreyra G, Ambrogio C, et al. Patient ventilator inter-
action and sleep in mechanically ventilated patients: pressure
support versus proportional assist ventilation. Crit Care Med 2007;
35:1048–1054.
29. Sinderby C, Beck J. Proportional assist ventilation and neurally
adjusted ventilatory assist—better approaches to patient ventilator
synchrony? Clin Chest Med 2008; 29:329–342.
30. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventila-
tion. Crit Care Med 1987; 15:462–466.
31. Baum M, Benzer H, Putensen C, Koller W, Putz G. [Biphasic positive
airway pressure (BIPAP)—a new form of augmented ventilation].
Anaesthesist 1989; 38:452–458.
32. Seymour CW, Frazer M, Reilly PM, Fuchs BD. Airway pressure release
and biphasic intermittent positive airway pressure ventilation: are
they ready for prime time? J Trauma 2007; 62:1298–1308.
33. Myers TR, MacIntyre NR. Respiratory controversies in the critical
care setting. Does airway pressure release ventilation offer impor-
tant new advantages in mechanical ventilator support? Respir Care
2007; 52:452–458.
34. Neumann P, Golisch W, Strohmeyer A, Buscher H, Burchardi H, Sy-
dow M. Influence of different release times on spontaneous breath-
ing pattern during airway pressure release ventilation. Intensive
Care Med 2002; 28:1742–1749.
35. Calzia E, Lindner KH, Witt S, et al. Pressure-time product and work
of breathing during biphasic continuous positive airway pressure
and assisted spontaneous breathing. Am J Respir Crit Care Med
1994; 150:904–910.
36. Rose L, Hawkins M. Airway pressure release ventilation and biphasic
positive airway pressure: a systematic review of definitional criteria.
Intensive Care Med 2008; 34:1766–1773.
37. Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-
term effects of two different ventilatory modes on oxygenation in
acute lung injury. Comparison of airway pressure release ventilation
and volume-controlled inverse ratio ventilation. Am J Respir Crit
Care Med 1994; 149:1550–1556.
38. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontane-
ous breathing during ventilatory support in patients with acute
lung injury. Am J Respir Crit Care Med 2001; 164:43–49.
39. Davis K Jr, Johnson DJ, Branson RD, Campbell RS, Johannigman JA,
Porembka D. Airway pressure release ventilation. Arch Surg 1993;
128:1348–1352.
40. Kaplan LJ, Bailey H, Formosa V. Airway pressure release ventilation
increases cardiac performance in patients with acute lung injury/
adult respiratory distress syndrome. Crit Care 2001; 5:221–226.
41. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV.
Airway pressure release ventilation as a primary ventilatory mode in
acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004;
48:722–731.
42. Siau C, Stewart TE. Current role of high frequency oscillatory
ventilation and airway pressure release ventilation in acute lung
injury and acute respiratory distress syndrome. Clin Chest Med 2008;
29:265–275.
43. Rathgeber J, Schorn B, Falk V, Kazmaier S, Spiegel T, Burchardi H.
The influence of controlled mandatory ventilation (CMV), intermit-
tent mandatory ventilation (IMV) and biphasic intermittent positive
airway pressure (BIPAP) on duration of intubation and consumption
of analgesics and sedatives. A prospective analysis in 596 patients
following adult cardiac surgery. Eur J Anaesthesiol 1997; 14:576–
582.
44. Habashi NM. Other approaches to open lung ventilation: airway
pressure release ventilation. Crit Care Med 2005; 33(suppl 3):S228–
S240.
45. Hess D, Mason S, Branson R. High-frequency ventilation design and
equipment issues. Respir Care Clin North Am 2001; 7:577–598.
46. Fessler HE, Derdak S, Ferguson ND, et al. A protocol for high fre-
quency oscillatory ventilation in adults: results from a roundtable
discussion. Crit Care Med 2007; 35:1649–1654.
47. Hamilton PP, Onayemi A, Smyth JA, et al. Comparison of con-
ventional and high-frequency ventilation: oxygenation and lung
pathology. J Appl Physiol 1983; 55:131–138.
48. Sedeek KA, Takeuchi M, Suchodolski K, et al. Open-lung protec-
tive ventilation with pressure control ventilation, high-frequency
oscillation, and intratracheal pulmonary ventilation results in similar
gas exchange, hemodynamics, and lung mechanics. Anesthesiology
2003; 99:1102–1111.
49. Imai Y, Nakagawa S, Ito Y, Kawano T, Slutsky AS, Miyasaka K. Com-
parison of lung protection strategies using conventional and high-
frequency oscillatory ventilation. J Appl Physiol 2001; 91:1836–1844.
50. van Heerde M, Roubik K, Kopelent V, Plötz FB, Markhorst DG.
Unloading work of breathing during high-frequency oscillatory
ventilation: a bench study. Crit Care 2006; 10:R103.
51. Derdak S, Mehta S, Stewart TE, et al; Multicenter Oscillatory
Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT)
Study Investigators. High-frequency oscillatory ventilation for acute
respiratory distress syndrome in adults: a randomized, controlled
trial. Am J Respir Crit Care Med 2002; 166:801–808.
52. Bollen CW, van Well GT, Sherry T, et al. High-frequency oscillatory
ventilation compared with conventional mechanical ventilation in
adult respiratory distress syndrome: a randomized controlled trial
[ISRCTN24242669]. Crit Care 2005; 9:R430–R439.
53. Mehta S, Granton J, MacDonald RJ, et al. High frequency oscillatory
ventilation in adults: the Toronto experience. Chest 2004; 126:518–
527.
54. Chan KP, Stewart TE, Mehta S. High-frequency oscillatory ventila-
tion for adult patients with ARDS. Chest 2007; 131:1907–1916.
ADDRESS: Eduardo Mireles-Cabodevila, MD, Department of Pulmonary
and Critical Care Medicine, University of Arkansas for Medical Sciences,
4301 West Markham Street, Slot 555, Little Rock, AR 77205; e mail mire-
lee@uams.edu.
WE ENCOURAGE YOU TO WRITE, either
to respond to an article published in the Journal
or to address a clinical issue of import ance to
you. You may submit
letters by mail, fax, or e-mail.
MAILING ADDRESS
Letters to the Editor
Cleveland Clinic Journal of Medicine
9500 Euclid Ave., NA32
Cleveland, OH 44195
FAX 216.444.9385
E-MAIL ccjm@ccf.org
Please be sure to include your full address,
phone number, fax number, and e-mail
address. Please write concisely, as space is
limited. Letters may be edited for style and
length. We cannot return materials sent.
Submission of a letter constitutes permission
for the Cleveland Clinic Journal of Medicine to
publish it in various editions and forms.
We Welcome Your Letters
We Welcome Your Letters
... Closed loop control ventilation was originally described by Tehrani (clinical engineering Professor at the University of California, USA) [4]. This was the first commercially available ventilator that used an 'optimal' targeting scheme [5]. A modified version of Otis equation is used to determine the optimum frequency of mechanical ventilation to minimize the work of breathing [6]. ...
... As discussed earlier, if the patient's RR is more than the target RR, it means patient is breathing on PS level. The PS level and patient effort can be seen on the ventilator monitor to decide on weaning [3][4][5][6][7][8][9][10][11]. Even with the closed loop ventilation there are advantages and disadvantages mentioned in Table 3. ...
Article
Full-text available
Closed loop control ventilation is a dual control mode of ventilation, which uses a closed loop control technique. This mode delivers controlled, time triggered, time cycled breaths when patient is not breathing and patient triggered flow cycled breaths when a patient is breathing. If the patient has spontaneous breaths, it delivers flow cycled breaths and allows the patient to trigger and breathe spontaneously, either in between the controlled breaths or fully spontaneously. This mode is pressure limited for control, assist control and spontaneous breath. The pressure will be varying and depends on the target tidal volume and uses auto-flow throughout the cycle. INTELLiVENT is a closed loop mode of ventilation, an advance over the closed loop control mode where the ventilator automatically adjusts settings and optimizes ventilation depending on the target settings and physiological information from the patient
... During improvement or deterioration of the patient condition, however, the operator needs to reevaluate the ventilator setup and the patients frequently, which is timeconsuming and requires appropriate expertise. To address this challenge, an alternative mode called adaptive pressure control (APC) was introduced in 1991, which delivered pressure-controlled breaths while guaranteeing tidal volume (5,6). According to the results from several original studies, however, no specific mode of mechanical ventilation is superior to another in terms of improving the outcomes and reducing mortality rate (7,8). ...
... 2022; 32(6):e119875. 5 ventilator manipulation by operator, were explained; however, the superiority or inferiority of this mode in terms of mortality was not determined (5). In another expert review by Turner, Rehder, and Cheifetz, the mortality rate among non-traditional modes of MV was discovered to remain unclear (8). ...
Article
Full-text available
Background: Mechanical ventilation (MV) is among the most common therapeutic modalities in pediatric intensive care units (PICU), which works based on a defined ventilation mode. Nowadays, conventional and alternative modes including adaptive pressure control (APC) and non-APC modes are frequently employed. Although MV can be helpful in many cases, it may cause some complications resulting in significant morbidity and mortality. Objectives: This study aimed to investigate the demographic features and complications of mechanically ventilated children in a PICU in Iran, as well as to compare different ventilation modes. Methods: A retrospective case-control study was conducted in PICUs of children’s medical center hospital - a tertiary referral pediatric hospital. Results: Of 66 patients included in this study, 33 patients were treated with APC modes, whereas 33 patients were treated with non-APC modes. The most common indications for intubation were respiratory failure (53%) and loss of consciousness (13.6%). The mean duration for intubation in patients with and without underlying disorder were 11.7 and 5.2 days, respectively (P-value < 0.01). The means of time for intubation in the APC and non-APC groups were 10 and 11.9 days, respectively (P-value 0.145). A total of 23 (34.8%) patients had complications, including death, misplacement of the endotracheal tube, atelectasis, unplanned extubation, etc. There was no significant difference between groups regarding the rates of complications, except for atelectasis. Thirteen (19.7%) patients had atelectasis (2 patients in APC group (6%) and 11 patients in non-APC group (33.3%)) (P-value = 0.022). The mortality rate was the same for the both groups (P-value = 1). Conclusions: In sum, the most common indication for intubation was respiratory failure. No significant difference was observed among patients treated with the APC, and non-APC modes in terms of the complications occurred, except for atelectasis which occurred more frequently in the non-APC group. Therefore, it was concluded that there was no difference between conventional and alternative modes of mechanical ventilation in terms of morbidity and mortality.
... [7,8] ASV first clinical application was described in 1994 by Laubscher et al. [9,10] It became commercially available in Europe in 1998, but it was not until 2007 that it was marketed in the United States. It is considered to be the first commercially available ventilator system that uses an "optimal" targeting schema [11] . In this context, "Optimal" means minimizing the mechanical WOB: The machine selects a VT and frequency that the patient's brain would presumably select if the patient were not connected to a ventilator. ...
... It can be used for total or partial ventilatory support during the initiation, maintenance or weaning from mechanical ventilation. [11] ASV Concept ASV is a new ventilatory mode, which uses a closed-loop controlled mode between breaths. The ventilator allows the clinician to set a maximum plateau pressure and desired minute ventilation based on the patient's ideal weight. ...
Article
Full-text available
Mechanical ventilation is one of the most commonly applied interventions in intensive care units. Despite its life-saving role, it can be a risky procedure for the patient if not applied appropriately. To decrease risks, new ventilator modes continue to be developed in an attempt to improve patient outcomes. Advances in ventilator modes include closed-loop systems that facilitate ventilator manipulation of variables based on measured respiratory parameters. Adaptive support ventilation (ASV) is a positive pressure mode of mechanical ventilation that is closed-loop controlled, and automatically adjust based on the patient's requirements. In order to deliver safe and appropriate patient care, clinicians need to achieve a thorough understanding of this mode, including its effects on underlying respiratory mechanics. This article will discuss ASV while emphasizing appropriate ventilator settings, their advantages and disadvantages, their particular effects on oxygenation and ventilation, and the monitoring priorities for clinicians.
... 3 Adaptive support ventilation (ASV) was originally described by Dr Fleur T Tehrani (clinical engineering Professor at the University of California, USA). 4 This was the first commercially available ventilator that used an 'optimal' targeting scheme. 5 A modified version of Otis equation is used to determine the optimum frequency of mechanical ventilation to minimise the work of breathing. 6 The rationale was to make the patient's breathing pattern comfortable and natural within safe limits, stimulate spontaneous breathing and reduce the weaning time. ...
... The PS level and patient effort can be seen on the ventilator monitor to decide on weaning. [3][4][5][6][7][8][9][10][11] IntelliVent-ASV (R) IntelliVent-ASV (R) is a fully automatic ventilation mode. 12 It is ASV mode which uses some additional special settings to autopilot the ventilation. ...
Article
Full-text available
Adaptive support ventilation (ASV) is a dual control mode of ventilation, which uses a closed loop control technique. This mode delivers controlled, time triggered and time cycled breaths when a patient is not breathing. If the patient has spontaneous breaths, it delivers flow cycled breaths and allows the patient to trigger and breathe spontaneously, either in between the controlled breaths or fully spontaneously. This mode is pressure limited for control, assist control and spontaneous breath. The pressure will vary depending on the target tidal volume and uses autoflow throughout the cycle. IntelliVent(R) is a closed loop mode of ventilation, an advance over the ASV mode where the ventilator automatically adjusts settings and optimises ventilation depending on the target settings and physiological information from the patient.
... The ASV mode delivers a tidal volume and a respiratory rate, presumably selected by the patient's brain. In addition, ASV calculates the dead space and delivers the breaths with a tidal volume more than the dead space (19). Based on this hypothesis, ASV can reduce the incidence of atelectasis. ...
... In the present study, during the spontaneous phase in the control group (SIMV mode), the patients experienced at least 1 episode of apnea and returned to the SIMV If the patient's respiratory rate is not sufficient for MMV, the ventilator delivers controlled breaths for achieving the expected MMV. Also, if the patient's inspiratory effort is not sufficient, the amount of pressure support is increased for having at least a tidal volume of 2.2 mL/kg to prevent atelectasis; therefore, this strategy could reduce atelectasis (19). Atelectasis also plays an important role in respiratory failure following surgery. ...
Article
Full-text available
Background: Pulmonary complications are common following cardiac surgery and can lead to increased morbidity, mortality, and healthcare costs. Atelectasis is the most common respiratory complication following cardiac surgery. One of the most important methods for reducing pulmonary complications is supportive care with protective ventilation strategies. In this study, we aimed to assess the effect of adaptive support ventilation (ASV) on atelectasis in patients undergoing cardiac surgery. Methods: In this single-blind randomized clinical trial, 115 patients, undergoing coronary artery bypass grafting, were randomly allocated into 2 groups: 57 patients in the intervention and 58 patients in the control group. Patients in the intervention group were weaned with ASV, while patients in the control group were managed using synchronized intermittent mandatory ventilation (SIMV) and pressure support. The incidence of atelectasis, duration of mechanical ventilation, manual ventilator setting, arterial blood gas measurements, and length of hospital stay were compared between the groups. Results: The incidence of atelectasis, number of changes in the manual ventilator setting, number of alarms, and length of hospital stay reduced in the intervention group. However, duration of mechanical ventilation and number of ABG measurements were not significantly different between the groups. Conclusions: The ASV mode could reduce the incidence of atelectasis and length of hospital stay. However, it did not reduce the duration of mechanical ventilation. It seems that ASV is not a superior mode for faster extubation. Keywords: Adaptive Support Ventilation; Coronary Artery Bypass Grafting; Atelectasis; Ventilator Weaning
... For example, recent findings indicate that, when compared with Positive Inspiratory Pressure (PIP) or tidal volume-targeted modes, proportional assist ventilation with Apnea back-up is more suitable for neonates with moderate lung diseases [28]. Moreover, several studies have been conducted to enhance the pressure and/or volume controls of mechanical ventilators (MVs), ensuring improved respiratory support during emergencies [29]. Nevertheless, the most extensively studied limitation of existing ventilators is their invasiveness, which contributed to a significant number of deaths during the peak of the COVID-19 pandemic [30]. ...
Article
Full-text available
The onset of Coronavirus Disease 2019 (COVID-19) led to significant shortages in mechanical ventilators worldwide. This situation prompted investigations to discover new methods for producing low-cost, safe ventilators. Among the popular types of ventilators are positive pressure ventilators (PPVs), conventional negative pressure ventilators (NPVs), and biphasic cuirass ventilators (BCVs). Unfortunately, PPVs were found to cause serious health complications for patients, not to mention their high manufacturing costs. Therefore, in this study, we introduce ExoventQ, an innovative, cost-effective respiratory support device derived from historical NPV designs. The system was meticulously designed, simulated, implemented, and tested in two modes: continuous negative extrathoracic pressure (CNEP) and cyclic negative pressure ventilation (CNPV). ExoventQ comprises a pressure vessel, a pumping system, and a control panel. Each of these three major subsystems was designed with considerations of pressure distribution, material, safety, cost, and portability. The ANSYS stress analysis of the polycarbonate pressure vessels indicates that a semi-cylindrical vessel can withstand more pressure than a prismatic vessel without experiencing permanent deformations or fractures. Subsequently, the structure was modified to adopt a squircle-shaped vessel to prevent the airway from tilting when assembled on the side, providing the patient with more space to lie comfortably. The pressure inside the vessel is regulated via a bypass butterfly valve actuated by a servo motor. The user interface was implemented on a Raspberry Pi touchscreen, allowing inputs to be entered by rotating the knobs on the screen, with the output displayed for monitoring. To ensure patient safety, a range of safety measures were implemented, including audio and visual alarms and a power switch that halts ventilation if the vacuum in the vessel drops below 40 mbar. The successful design and implementation of this system have the potential to pave the way for the mass production of safe and affordable NPVs to address pulmonary complications.
... The first clinical application was described in the literature in 1994 by Laubscher and colleagues [5,6] that characterized with assist-control, pressure-targeted, time-cycled mode of ventilation. It is considered to be the first available ventilator system that uses an "optimal" targeting schema [7]. When using ASV, the preset parameters are far less than other modes. ...
Preprint
Full-text available
Background The purpose of the study is to examine whether the adaptive support ventilation (ASV) mode compared with conventional ventilation reduces the duration of mechanical ventilation (MV) in patients with acute respiratory failure. Methods We searched PubMed, the Cochrane Library Central Register of Controlled Trials, EMBASE and Web of Science databases from inception through July 27, 2019. We considered all the randomized controlled studies (RCTs) that examined the efficacy of ASV in comparison with conventional ventilation in mechanically ventilated adults. The primary outcomes were (1) the length of MV, (2) weaning duration and (3) length of stay (LOS) in ICU. Results We included three RCTs for the analysis enrolling a total of 374 patients. Patients treated with ASV had a lower weaning duration than patients treated with conventional ventilation (MD -28.98 [95% CI -42.42, -15.54, p˂0.0001]). Then, 28-day mortality was not different between the two groups (OR 0.95 [95%CI 0.6, 1.52, p=0.83; I2=0%, p=0.96]). The incidence of ventilator-associated pneumonia and sedation level was not included into the quantitative analysis. Conclusions The study showed that a lower number of duration of MV and a shorter number of weaning duration in acute hypoxemic respiratory failure patients treated with ASV than conventional ventilation. Keywords: pulmonary infection; critically ill patients; adaptive support ventilation; hypoxemic respiratory failure Background Acute hypoxemic respiratory failure is a severe disorder of the respiratory system to maintain oxygenation or eliminate carbon dioxide (CO2), leading to a series of metabolic disorders and physiological dysfunction. Mechanical ventilation (MV) serve as a lifesaving therapy is widely employed in intensive care units (ICU) for treating clinical symptoms related to critically illness.[1,2] Employment of mechanical ventilation in patients could help effectively to replace, control and change spontaneous breathing, reduce or eliminate respiratory muscle oxygen consumption, increasing ventilation and improving ventilation[3], removing the residual mucous in airway.[4] The choice of ventilation mode is such a very important issue in ICU that clinicians capable to choose the ventilation mode and adapt the ventilator controls according to the patient's respiratory mechanics.
... Fundamentally, ventilation can be divided into several groups by the level of invasion, the mode used and the target. Typically, MV is first split into invasive or non-invasive, determined if the patient is intubated or not, and then subdivided into control or support modes, depending on the patient's breathing efforts and sedation, and finally, pressure or volume controlled modes [43][44][45]. Figure 2 describes three tiers that roughly align with the decision-making process to completely define each of the three dimensions. The box representing control mode non-invasive ventilation is shaded to designate that this combination of settings is rarely employed [45]. ...
Article
Full-text available
Background Mechanical ventilation is an essential therapy to support critically ill respiratory failure patients. Current standards of care consist of generalised approaches, such as the use of positive end expiratory pressure to inspired oxygen fraction (PEEP–FiO2) tables, which fail to account for the inter- and intra-patient variability between and within patients. The benefits of higher or lower tidal volume, PEEP, and other settings are highly debated and no consensus has been reached. Moreover, clinicians implicitly account for patient-specific factors such as disease condition and progression as they manually titrate ventilator settings. Hence, care is highly variable and potentially often non-optimal. These conditions create a situation that could benefit greatly from an engineered approach. The overall goal is a review of ventilation that is accessible to both clinicians and engineers, to bridge the divide between the two fields and enable collaboration to improve patient care and outcomes. This review does not take the form of a typical systematic review. Instead, it defines the standard terminology and introduces key clinical and biomedical measurements before introducing the key clinical studies and their influence in clinical practice which in turn flows into the needs and requirements around how biomedical engineering research can play a role in improving care. Given the significant clinical research to date and its impact on this complex area of care, this review thus provides a tutorial introduction around the review of the state of the art relevant to a biomedical engineering perspective. Discussion This review presents the significant clinical aspects and variables of ventilation management, the potential risks associated with suboptimal ventilation management, and a review of the major recent attempts to improve ventilation in the context of these variables. The unique aspect of this review is a focus on these key elements relevant to engineering new approaches. In particular, the need for ventilation strategies which consider, and directly account for, the significant differences in patient condition, disease etiology, and progression within patients is demonstrated with the subsequent requirement for optimal ventilation strategies to titrate for patient- and time-specific conditions. Conclusion Engineered, protective lung strategies that can directly account for and manage inter- and intra-patient variability thus offer great potential to improve both individual care, as well as cohort clinical outcomes.
... basınç limitli zaman döngülü bir moddur 1 . APRV'de dakika ventilasyonu akciğer kompliyansına, havayolu rezistansına ve T low ve hastanın solunum eforunun gücüne bağlıdır.2 ...
Article
In this paper, three different advanced mechanical ventilation modes, pressure regulated volume control ventilation (PRVC), proportional assist ventilation (PAV), and adaptive support ventilation (ASV) are designed and simulated on the computer via MATLAB/Simulink. In the algorithms of advanced ventilation modes, a closed-loop control structure is used and recursive least squares method is considered for the estimation of respiratory mechanics. The designed algorithms are then applied to the human respiratory system model for the active and/or passive patient cases. Simulation results show that such algorithms can be designed and simulated on the computer successfully. In addition, the simulation environment helps us to understand the working principles of the advanced modes and to see the results such as ventilator waveforms, the effect of the parameter changes. Moreover, it also allows us to improve and test the algorithms and strategies quickly and efficiently.
Article
Full-text available
The objective of this study was to identify the definitional criteria for the pressure-limited and time-cycled modes: airway pressure release ventilation (APRV) and biphasic positive airway pressure (BIPAP) available in the published literature. Systematic review. Medline, PubMed, Cochrane, and CINAHL databases (1982-2006) were searched using the following terms: APRV, BIPAP, Bilevel and lung protective strategy, individually and in combination. Two independent reviewers determined the paper eligibility and abstracted data from 50 studies and 18 discussion articles. Of the 50 studies, 39 (78%) described APRV, and 11 (22%) described BIPAP. Various study designs, populations, or outcome measures were investigated. Compared to BIPAP, APRV was described more frequently as extreme inverse inspiratory:expiratory ratio [18/39 (46%) vs. 0/11 (0%), P = 0.004] and used rarely as a noninverse ratio [2/39 (5%) vs. 3/11 (27%), P = 0.06]. One (9%) BIPAP and eight (21%) APRV studies used mild inverse ratio (>1:1 to < or =2:1) (P = 0.7), plus there was increased use of 1:1 ratio [7 (64%) vs. 12 (31%), P = 0.08] with BIPAP. In adult studies, the mean reported set inspiratory pressure (PHigh) was 6 cm H2O greater with APRV when compared to reports of BIPAP (P = 0.3). For both modes, the mean reported positive end expiratory pressure (PLow) was 5.5 cm H2O. Thematic review identified inconsistency of mode descriptions. Ambiguity exists in the criteria that distinguish APRV and BIPAP. Commercial ventilator branding may further add to confusion. Generic naming of modes and consistent definitional parameters may improve consistency of patient response for a given mode and assist with clinical implementation.
Article
Background: Elevated airway pressures during mechanical ventilation are associated with hemodynamic compromise and pulmonary barotrauma. We studied the cardiopulmonary effects of a pressure-limited mode of ventilation (airway pressure release ventilation) in patients with the adult respiratory distress syndrome.Methods: Fifteen patients requiring intermittent mandatory ventilation (IMV) and positive end-expiratory pressure (PEEP) were studied. Following measurement of hemodynamic and ventilatory data, all patients were placed on airway pressure release ventilation (APRV). Cardiorespiratory measurements were repeated after a 2-hour stabilization period.Results: During ventilatory support with APRV, peak inspiratory pressure (62±10 vs 30±4 cm H2O) and PEEP (11±4 vs 7±2 cm H2O) were reduced compared with IMV. Mean airway pressure was higher with APRV (18±5 vs 24±4 cm H2O) There were no statistically significant differences in gas exchange or hemodynamic variables. Both cardiac output (8.7±1.8 vs 8.4±2.0 L/min) and partial pressure of oxgen in arterial blood (79 ±9 vs 86±11 mm Hg) were essentially unchanged.Conclusions: Our results suggest that while airway pressure release ventilation can provide similar oxygenation and ventilation at lower peak and end-expiratory pressures, this offers no hemodynamic advantages.(Arch Surg. 1993;128:1348-1352)
Article
Pressure control ventilation (PCV), high-frequency oscillation (HFO), and intratracheal pulmonary ventilation (ITPV) may all be used to provide lung protective ventilation in acute respiratory distress syndrome, but the specific approach that is optimal remains controversial. Saline lavage was used to produce acute respiratory distress syndrome in 21 sheep randomly assigned to receive PCV, HFO, or ITPV as follows: positive end-expiratory pressure (PCV and ITPV) and mean airway pressure (HFO) were set in a pressure-decreasing manner after lung recruitment that achieved a ratio of Pao2/Fio2 > 400 mmHg. Respiratory rates were 30 breaths/min, 120 breaths/min, and 8 Hz, respectively, for PCV, ITPV, and HFO. Eucapnia was targeted with peak carinal pressure of no more than 35 cm H2O. Animals were then ventilated for 4 h. There were no differences among groups in gas exchange, lung mechanics, or hemodynamics. Tidal volume (PCV, 8.9 +/- 2.1 ml/kg; ITPV, 2.7 +/- 0.8 ml/kg; HFO, approximately 2.0 ml/kg) and peak carinal pressure (PCV, 30.6 +/- 2.6 cm H2O; ITPV, 22.3 +/- 4.8 cm H2O; HFO, approximately 24.3 cm H2O) were higher in PCV. Pilot histologic data showed greater interstitial hemorrhage and alveolar septal expansion in PCV than in HFO or ITPV. These data indicate that HFO, ITPV, and PCV when applied with an open-lung protective ventilatory strategy results in the same gas exchange, lung mechanics, and hemodynamic response, but pilot data indicate that lung injury may be greater with PCV.
Article
The response to proportional assist ventilation (PAV) was tested in four normal subjects during heavy exercise and in five ventilator-dependent patients recovering from assorted medical disorders. The apparatus consisted of a rolling-seal piston coupled to a motor that generated pressure in proportion to inspired flow and inspired volume, with the gains adjusted such that the proportionality between airway pressure (Paw) and instantaneous patient-generated pressure (Pmus) was approximately 1:1 (i.e., machine-amplified patient effort by a factor of 2). Normal subjects responded to PAV by decreasing their own effort, as judged from esophageal pressure, such that the changes in ventilation and breathing pattern were rather small (VE: 64.8 +/- 3.6 during PAV versus 56.0 +/- 4.3, p less than 0.01; VT: 2.39 +/- 0.24 versus 2.02 +/- 0.17, p less than 0.05; f: 27.5 +/- 1.9 versus 28.0 +/- 2.2, NS). In patients, elastance ranged from 20 to 35 cm H2O cm/L, resistance ranged from 5 to 10 cm H2O/L/s, and maximal inspiratory pressure ranged from -16 to -65 cm H2O. After a period of observation during synchronized intermittent mechanical ventilation (SIMV) the patient was switched to PAV and maintained on it for 1 to 3 h. No patient had to be replaced on SIMV because of discomfort or deterioration in any of the monitored variables. During PAV peak airway pressure was less than half the value observed with the IMV breaths (16.6 +/- 2.4 versus 35.4 +/- 3.4 cm H2O, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Article
The relation between inspiratory effort and ventilatory return (flow and volume) is usually abnormal in patients who require ventilatory support because of respiratory distress. Although all available support methods provide the patient with greater ventilation than would obtain with the same effort while unsupported, the relation between instantaneous effort and ventilatory consequences is not normalized. We describe an approach with which the ventilator simply amplifies patient instantaneous effort throughout inspiration while leaving the patient with complete control over all aspects of breathing pattern (tidal volume, inspiratory and expiratory durations, and flow patterns). This approach is implemented by monitoring the instantaneous rate (V) and volume (V) of gas flow from ventilator to patient and causing applied pressure (P) to change according to the equation of motion [P = f1(V) + f2(V)], where f1 and f2 are appropriately selected functions for the relation between pressure and volume (elastic assist) and pressure and flow (resistive assist). There are several potential advantages to this approach: (1) greater comfort; (2) reduction of peak airway pressure required to sustain ventilation and, hence, the potential for avoiding intubation; (3) less likelihood of overventilation; (4) preservation and enhancement of patient's own reflex, behavioral, and homeostatic control mechanisms since the ventilator essentially becomes an extension of the patient's own muscles; and (5) improved efficiency of negative pressure ventilation.
Article
Two modes of combining spontaneous breathing and mechanical ventilation are already in use: periodic mechanical support always followed by a period of spontaneous breathing (intermittent mandatory ventilation; IMV) and mechanical support of each spontaneous breath (inspiratory assistance; IA). Biphasic positive airway pressure (BIPAP), in contrast, is based on neither of the above mentioned principles. It is rather a mixture of pressure controlled (PC) ventilation and spontaneous breathing, which is unrestricted in each phase of the respiratory cycle. The BIPAP circuit switches between a high (Phi) and a low (Plo) airway pressure level in an adjustable time sequence. At both pressure levels the patient can breathe spontaneously in a continuous positive airway pressure system (CPAP). The volume displacement caused by the difference between Phi and Plo and the BIPAP frequency (F) contribute the mechanical ventilation to total ventilation. Duration of the Phi and the Plo phases can be independently adjusted. Similar to the I:E ratio during controlled ventilation, the phase time ratio (PhTR) is calculated as the ratio between the durations of the two pressure phases. A PhTR greater than 1:1 is called IR-BIPAP. A BIPAP system can be set up either as a continuous flow system, or as a demand valve system. A continuous-flow BIPAP system consists of a high-flow CPAP system, a reservoir bag, and a pneumatically controlled membrane valve in the expiratory limb. A magnetic valve operated by an impulse generator switches between Phi and Plo, controlling the pop-off pressures of the expiratory valve.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
Airway pressure release ventilation (APRV) delivers continuous positive airway pressure (CPAP) and may support ventilation simultaneously. This investigation tested whether, after acute lung injury (ALI), APRV promotes alveolar ventilation and arterial oxygenation without increasing airway pressure (Paw) above the CPAP level and without depressing cardiac function. Ten anesthetized dogs randomly received either intermittent positive-pressure ventilation (IPPV) or APRV. APRV was delivered with a continuous-flow CPAP system. Expiration occurred when a switch in the expiratory limb opened and Paw decreased to near-ambient, which decreased lung volume. After baseline data collection, ALI was induced by infusing oleic acid iv. Two hours later, IPPV and APRV were administered randomly, and data were collected. With normal lungs, APRV and IPPV achieved similar gas exchange and hemodynamic function. During ALI, arterial oxygenation was improved, and peak Paw which did not exceed the CPAP level, was lower during APRV. Similar minute ventilations were delivered by both modes but resulted in lower PaCO2 with APRV. Thus, APRV decreased physiologic deadspace ventilation. Hemodynamic status was similar during both modes. Therefore, APRV is an improved method of oxygenation and ventilatory support for patients with ALI that will allow unrestricted spontaneous ventilation and may decrease the incidence of barotrauma.
Article
Oxygenation and lung pathology were compared during conventional (CMV) and high frequency (HFO) ventilation in an animal model of pulmonary injury. Adult rabbits (2-4 kg) were studied under general anesthesia. Following tracheostomy, pulmonary injury was induced by saline lavage. During 5 h of either HFO or CMV, HFO produces a marked improvement in oxygenation (407, 407, and 409 Torr at 1, 3, and 5 h, respectively) compared with CMV (98, 129, and 87 Torr; P < 0.005). After 5 h each animal was killed and the lungs were fixed for microscopy. All CMV animals developed diffuse hyaline membranes, whereas the HFO animals did not. In a second series of experiments, HFO and CMV were attempted for 20 h. All CMV animals died before 20 h, [mean time of death = 10.6 h, final arterial blood O2 partial pressure Pa(O2) = 56 Torr, arterial blood CO2 partial pressure (Pa(CO2) = 56 Torr, pH = 7.15], whereas 4 of 5 HFO animals completed the 20-h protocol (final Pa(O2) and Pa(CO2), 403 and 37 Torr, respectively, pH = 7.29). Again, the CMV animals developed diffuse hyaline membranes, whereas the HFO animals did not. This study confirms our previous findings that HFO improves gas exchange in the acutely injured lung. Furthermore, the lower lung volume and/or larger phasic pressure-volume fluctuations associated with CMV can induce pulmonary damage. Avoidance of low lung volume and large pressure-volume changes through the use of HFO results in reduced pulmonary damage.